Voro and Alloy Partner on Next-Gen T-Cell Cancer Therapies
SAN DIEGO, Calif. and BOSTON, Mass., June 20, 2026 Voro Therapeutics and Alloy Therapeutics have announced a strategic research...
antibody engineering
Advertisement
FiberSense CGM System Achieves CE Mark for Market Launch
BASEL, Switzerland, June 17, 2026 FiberSense AG has announced that its innovative FiberSense Continuous Glucose Monitoring (CGM) System has...
Protillion Biosciences Partners With Merck on AI Drug Discovery
CARLSBAD, Calif., June 16, 2026 Protillion Biosciences has announced a significant multi-target drug discovery collaboration and license agreement with...
Inhibrx Reports Progress for INBRX-106 in HNSCC Trial
SAN DIEGO – May 8, 2026 Inhibrx Biosciences, Inc., a clinical-stage biopharmaceutical company focused on oncology and rare diseases,...
Innovent Showcases Tri-Specific Autoimmune Therapy Data
SAN FRANCISCO & SUZHOU, China, April 9, 2026 Innovent Biologics, Inc. has unveiled preclinical data for its novel tri-specific...
Advertisements
Nona Biosciences Names Chief AI Officer to Drive A³ Drug Discovery
Cambridge, MA – December 3, 2025: Nona Biosciences has appointed Dr. Hongjiang Miao as its first Chief AI Officer,...
Advertisement
